Common Stock, Shares, Outstanding of ADMA BIOLOGICS, INC. from 30 Jun 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
ADMA BIOLOGICS, INC. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 30 Jun 2011 to 31 Dec 2025.
  • ADMA BIOLOGICS, INC. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 237,874,496, a 0.53% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

ADMA BIOLOGICS, INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 237,874,496 +1,253,951 +0.53% 31 Dec 2025 10-K 25 Feb 2026 2025 FY
Q3 2025 238,332,393 +1,953,786 +0.83% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 238,567,308 +5,540,572 +2.4% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 238,532,252 +6,762,487 +2.9% 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 236,620,545 +10,557,513 +4.7% 31 Dec 2024 10-K 25 Feb 2026 2025 FY
Q3 2024 236,378,607 +10,420,523 +4.6% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 233,026,736 +8,499,988 +3.8% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 231,769,765 +9,507,177 +4.3% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 226,063,032 +4,246,102 +1.9% 31 Dec 2023 10-K 18 Mar 2025 2024 FY
Q3 2023 225,958,084 +29,181,213 +15% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 224,526,748 +28,170,516 +14% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 222,262,588 +25,915,059 +13% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 221,816,930 +26,003,113 +13% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 196,776,871 +58,463,054 +42% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 196,356,232 +64,484,206 +49% 30 Jun 2022 10-Q 10 Aug 2022 2022 Q2
Q1 2022 196,347,529 +73,302,548 +60% 31 Mar 2022 10-Q 11 May 2022 2022 Q1
Q4 2021 195,813,817 +90,910,929 +87% 31 Dec 2021 10-K 23 Mar 2023 2022 FY
Q3 2021 138,313,817 +48,697,641 +54% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 131,872,026 +45,522,045 +53% 30 Jun 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 123,044,981 +36,699,668 +43% 31 Mar 2021 10-Q 12 May 2021 2021 Q1
Q4 2020 104,902,888 +45,584,533 +77% 31 Dec 2020 10-K 24 Mar 2022 2021 FY
Q3 2020 89,616,176 +30,297,821 +51% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 86,349,981 +27,032,175 +46% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 86,345,313 +39,992,245 +86% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 59,318,355 +12,965,287 +28% 31 Dec 2019 10-K 25 Mar 2021 2020 FY
Q3 2019 59,318,355 +12,967,112 +28% 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 59,317,806 +12,968,292 +28% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 46,353,068 +9,626,984 +26% 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 46,353,068 +9,627,569 +26% 31 Dec 2018 10-K 13 Mar 2020 2019 FY
Q3 2018 46,351,243 +29,148,999 +169% 30 Sep 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 46,349,514 +29,167,193 +170% 30 Jun 2018 10-Q 10 Aug 2018 2018 Q2
Q1 2018 36,726,084 +23,839,343 +185% 31 Mar 2018 10-Q 14 May 2018 2018 Q1
Q4 2017 36,725,499 +23,838,758 +185% 31 Dec 2017 10-K 13 Mar 2019 2018 FY
Q3 2017 17,202,244 +4,315,503 +33% 30 Sep 2017 10-Q 03 Nov 2017 2017 Q3
Q2 2017 17,182,321 +4,295,580 +33% 30 Jun 2017 10-Q 11 Aug 2017 2017 Q2
Q1 2017 12,886,741 +2,173,654 +20% 31 Mar 2017 10-Q 12 May 2017 2017 Q1
Q4 2016 12,886,741 +2,173,654 +20% 31 Dec 2016 10-K 29 Mar 2018 2017 FY
Q3 2016 12,886,741 +2,173,654 +20% 30 Sep 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 12,886,741 +2,181,168 +20% 30 Jun 2016 10-Q 12 Aug 2016 2016 Q2
Q1 2016 10,713,087 +7,514 +0.07% 31 Mar 2016 10-Q 13 May 2016 2016 Q1
Q4 2015 10,713,087 +1,421,264 +15% 31 Dec 2015 10-K 24 Feb 2017 2016 FY
Q3 2015 10,713,087 +1,421,264 +15% 30 Sep 2015 10-Q 10 Nov 2015 2015 Q3
Q2 2015 10,705,573 +1,413,750 +15% 30 Jun 2015 10-Q 11 Aug 2015 2015 Q2
Q1 2015 10,705,573 +1,413,750 +15% 31 Mar 2015 10-Q 12 May 2015 2015 Q1
Q4 2014 9,291,823 0 0% 31 Dec 2014 10-K 23 Mar 2016 2015 FY
Q3 2014 9,291,823 +3,420,821 +58% 30 Sep 2014 10-Q 10 Nov 2014 2014 Q3
Q2 2014 9,291,823 +3,420,821 +58% 30 Jun 2014 10-Q 11 Aug 2014 2014 Q2
Q1 2014 9,291,823 +3,420,821 +58% 31 Mar 2014 10-Q 12 May 2014 2014 Q1
Q4 2013 9,291,823 +3,420,821 +58% 31 Dec 2013 10-K 09 Mar 2015 2014 FY
Q3 2013 5,871,002 +1,216,699 +26% 30 Sep 2013 10-Q 12 Nov 2013 2013 Q3
Q2 2013 5,871,002 +1,216,699 +26% 30 Jun 2013 10-Q 12 Aug 2013 2013 Q2
Q1 2013 5,871,002 +1,216,699 +26% 31 Mar 2013 10-Q 14 May 2013 2013 Q1
Q4 2012 5,871,002 +5,462,413 +1337% 31 Dec 2012 10-K 28 Mar 2014 2013 FY
Q3 2012 4,654,303 +2,154,303 +86% 30 Sep 2012 10-Q 13 Nov 2012 2012 Q3
Q2 2012 4,654,303 +2,154,303 +86% 30 Jun 2012 10-Q 14 Aug 2012 2012 Q2
Q1 2012 4,654,303 31 Mar 2012 10-Q 15 May 2012 2012 Q1
Q4 2011 408,589 31 Dec 2011 10-K 06 Mar 2013 2012 FY
Q3 2011 2,500,000 30 Sep 2011 10-Q 28 Oct 2011 2011 Q3
Q2 2011 2,500,000 30 Jun 2011 10-Q 01 Feb 2012 2012 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.